1. Home
  2. STRO

as 07-26-2024 4:00pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.

Founded: N/A Country:
United States
United States
Employees: N/A City: SOUTH SAN FRANCISCO
Market Cap: 339.4M IPO Year: 2018
Target Price: $12.50 AVG Volume (30 days): 891.1K
Analyst Decision: Strong Buy Number of Analysts: 8
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.88 EPS Growth: N/A
52 Week Low/High: $2.01 - $6.13 Next Earning Date: 08-08-2024
Revenue: $154,065,000 Revenue Growth: 106.66%
Revenue Growth (this year): -62.68% Revenue Growth (next year): -20.15%

STRO Daily Stock ML Predictions

Share on Social Networks: